Tom Lynch: Fred Hutch at Yale Medicine for the Lung Cancer SPORE workshop

Tom Lynch, President and Chief Executive Officer at Fred Hutch, shared a post on X:

“Fred Hutch is well represented today at Yale Medicine for the Lung Cancer SPORE workshop, where we’re celebrating the 20th anniversary of the discovery of EGFR mutations. I was involved in that work 20 yrs ago, and I’m proud to continue plotting the course of research to come.”

Source: Tom Lynch/X